Anti-ANTXR2 Recombinant Antibody Products

Loading...

Anti-ANTXR2 Products

+ Filter
Loading...
View More Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Creative Biolabs is a recognized name for infectious disease and oncology research and is dedicated to helping you discover and develop the best high quality anti-ANTXR2 recombinant antibodies for your research. Anthrax Toxin Receptor 2 (ANTXR2), also known as Capillary Morphogenesis Gene 2 (CMG2), has a well-established role in anthrax pathogenesis, but it is also a key player in angiogenesis. We have the validated antibodies you need to study its role as a receptor for anthrax toxins, as well as its role as a putative anti-angiogenic target for cancer.

ANTXR2: A Dual-Role Protein in Anthrax Pathogenesis and Angiogenesis

ANTXR2, also known as CMG2, is a transmembrane protein that has been best characterized as the receptor through which anthrax toxins enter host cells during infection. However, it also has well-established roles in a variety of normal physiological processes, most notably angiogenesis, or blood vessel formation. It binds to extracellular matrix components including collagen IV and laminin, and because of its high expression in tumor vasculature, it has been explored as a target for anti-cancer therapies, in an attempt to "starve" the tumor.

Alternative Names

Anthrax Toxin Receptor 2; Capillary Morphogenesis Gene 2 Protein; Capillary Morphogenesis Protein 2; CMG-2; CMG2; HFS; ISH; JHF

Background

This gene encodes a receptor for anthrax toxin. The protein binds to collagen IV and laminin, suggesting that it may be involved in extracellular matrix adhesion. Mutations in this gene cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Multiple transcript variants encoding different isoforms have been found for this gene.

Protein class

Disease related genes, Human disease related genes, Plasma proteins

Predicted location

Intracellular, Membrane (different isoforms)

Single cell type specificity

Cell type enhanced (Endometrial stromal cells)

Immune cell specificity

Low immune cell specificity

Cell line specificity

Cell line enhanced (ASC diff, HHSteC, LHCN-M2, U-2197)

Interaction

Binds laminin, and possibly also collagen type IV. (Microbial infection) Interacts (via VWFA domain) with the protective antigen (PA) of B.anthracis.

Molecular function

Receptor

More Types Infomation

Anti-ANTXR2 rAb Products

Our anti-ANTXR2 recombinant antibodies are designed with superior specificity and high affinity in mind. They are validated to differentiate between ANTXR2 and its homolog ANTXR1 so that you can be confident you are getting the right data every time. Use our rAbs to study toxin binding and internalization, or to evaluate expression on tumor tissues, with the accuracy you need to power your research.

Table 1. Featured anti-ANTXR2 recombinant antibody products at Creative Biolabs.

Cat. No. Product Name Target Species Host Species Applications
MOR-0181 Hi-Affi™ Rabbit Anti-ANTXR2 Recombinant Antibody (clone DS181AB) (CAT#: MOR-0181) Human Rabbit IgG WB, IHC, ICC

Customer Reviews

Excellent
Da***l
Hi-Affi™ Rabbit Anti-ANTXR2 Recombinant Antibody (clone DS181AB) (CAT#: MOR-0181)
This anti-ANTXR2 antibody worked wonderfully in our anti-angiogenic studies. The IHC staining on tumor blood vessels was very sharp and specific, so we could quantify them accurately.
19/Jun/2023

rAb Production

At Creative Biolabs, we understand the unique needs of infectious disease and cancer researchers and leverage the most advanced antibody production platforms to fulfill them. We express our anti-ANTXR2 recombinant antibodies in optimized mammalian cell expression systems to produce fully functional antibodies with the correct folding and glycosylation.

Featured Anti-ANTXR2 Recombinant Antibody Production PlatformsMilligram-scale. (Creative Biolabs Original)
Fig.1 Milligram-scale anti-ANTXR2 recombinant antibody production.

Gram-scale. (Creative Biolabs Original)Fig.2 Gram-scale anti-ANTXR2 recombinant antibody production.

rAb Modalities

Creative Biolabs offers a wide variety of anti-ANTXR2 recombinant antibody modalities to suit your needs. We also provide customization services to produce the format that is most useful for your research, such as full-length IgGs for in vivo blocking studies, Fab fragments for structural studies, or antibody-drug conjugate (ADC) services to develop ADCs, empowering researchers around the world to explore this receptor with speed and efficiency.

ANTXR2 antibody production and modalities. (Creative Biolabs Original)Fig.3 Full-length anti-ANTXR2 recombinant antibody production and modalities.

ANTXR2-Targeted Drug Information

Table 2. Public drug targeting ANTXR2.

Company Research phase Classification Condition
Elusys Therapeutics Approved by FDA Monoclonal Antibody Treatment and prophylaxis of inhalational anthrax
Human Genome Sciences (GSK) Approved by FDA Monoclonal Antibody Treatment and prophylaxis of inhalational anthrax
Adalta Phase 1 (completed) i-body (a humanized single-domain antibody) Idiopathic Pulmonary Fibrosis (by targeting CXCR4, but derived from ANTXR2-binding scaffold)
Various Academic/Biotech Preclinical Antibody-Drug Conjugate (ADC) Solid Tumors (e.g., Non-Small Cell Lung Cancer)

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

Partner with Creative Biolabs for the best high quality anti-ANTXR2 recombinant antibodies for your research. We understand the importance of studying this multifunctional receptor, and we have the validated antibodies you need to study its role in anthrax pathogenesis and its role as a putative anti-angiogenic target. Contact our experts today to learn more.

Go to compare

Go to compare